pharmapprove.com
  • Home
  • What we do
    • Advisory Committee Preparation
    • Oral Explanation (OE)
    • Scientific Advisory Boards
    • Strategic Communications
  • About us
  • Our people
  • Our Perspective
  • Contact
  • Contact
Select Page
Value Communications and Negotiations – are you prepared?

Value Communications and Negotiations – are you prepared?

by Denise Strömquist | Mar 26, 2021 | Event, Featured, Insights, News

During the DIA Europe meeting 15-19 of March, NDA consultants conducted a session on value communication for new products or therapies. Chairing the session was Steffen Thirstrup from NDA Advisory Board, accompanied by Carole Longson, Association of the British...
Team Spotlight: Dr. Steffen Thirstrup

Team Spotlight: Dr. Steffen Thirstrup

by Denise Strömquist | Nov 18, 2020 | Featured, News, Staff Spotlight

Steffen is one of NDA Groups’s experts on Oral Explanations. Prior to joining NDA seven years ago, Steffen spent nine years as the Chief Medical Officer and Head of Division at the Danish Medicines Agency. During five of those he also acted as the Danish...
Importance of Excellence in Scientific and Regulatory Communications

Importance of Excellence in Scientific and Regulatory Communications

by Lisa Peluso | Sep 27, 2020 | Featured, Insights

By Lisa Peluso While we work with global companies to strategize and execute successful engagements with regulators at critical junctures such as Oral Explanations and FDA Advisory Committee meetings, excellent communications are the backbone of streamlined, efficient...
Proactive planning and communication with FDA is critical to regulatory success

Proactive planning and communication with FDA is critical to regulatory success

by Laurie Smaldone | Sep 18, 2020 | Featured, Insights

“Of a good beginning cometh a good end.” Chinese Proverb By Laurie Smaldone Alsup, MD It’s common knowledge that communicating early and regularly with the FDA is critical to regulatory success. Getting the review division’s opinions on study design and plans,...
Team Spotlight: Dr. Steffen Thirstrup

Team Spotlight: Dr. Frank Casty

by Denise Strömquist | Aug 31, 2020 | Featured, News, Staff Spotlight

Frank is a pulmonary/critical care physician with over 25 years of experience in the pharmaceutical industry. He has worked across numerous therapeutic areas including allergy, respiratory, cardiovascular, endocrinology and metabolism, and has led several NDA and MAA...
FDA Advisory Committees During COVID-19: When Face to Face is Not an Option

FDA Advisory Committees During COVID-19: When Face to Face is Not an Option

by Michael Piperno | Aug 7, 2020 | Featured, Insights

8 Tips to Set Your Team Up for Success By Michael Piperno There is perhaps no regulatory event as intense as an FDA Advisory Committee meeting. The stakes are high, and the applicant team has spent the last six months getting ready to deliver and defend a cohesive and...
« Older Entries

Recent Posts

  • Value Communications and Negotiations – are you prepared?
  • Team Spotlight: Dr. Steffen Thirstrup
  • Importance of Excellence in Scientific and Regulatory Communications
  • Proactive planning and communication with FDA is critical to regulatory success
  • Leveraging Expedited Regulatory Pathways to Optimize Drug Development

Recent Comments

  • FDA Advisory Committees During COVID-19: When Face to Face is Not an Option - pharmapprove.com on Remote FDA Advisory Committee Meetings: Prepare for the Worst and Bring your Best

Archives

  • March 2021
  • November 2020
  • September 2020
  • August 2020
  • July 2020
  • April 2020
  • January 2020

CONTACT DETAILS

200 Princeton South
Corporate Center
Suite 340
Ewing, NJ 08628
USA

T. +1 609.583.1990
E. info@pharmapprove.com

Our Services

Advisory Committees
Oral Explanations (OE)
Scientific Advisory Boards
Strategic Communication

Helpful Links

Privacy Policy

Connect

  • Follow
  • Follow